Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma

BACKGROUND: Ex vivo drug screening refers to the out-of-body assessment of drug efficacy in patient derived vital tumor cells. The purpose of these methods is to enable functional testing of patient specific efficacy of anti-cancer therapeutics and personalized treatment strategies. Such approaches...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Cancer
Asıl Yazarlar: Mäkelä, Rami, Arjonen, Antti, Härmä, Ville, Rintanen, Nina, Paasonen, Lauri, Paprotka, Tobias, Rönsch, Kerstin, Kuopio, Teijo, Kononen, Juha, Rantala, Juha K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7313172/
https://ncbi.nlm.nih.gov/pubmed/32576176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07092-w
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller